Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Loxapine recalled?

Not under an active recall. Loxapine was recalled 10 times in the past — all now closed. Most recent: May 1, 2018.

Most common reason: Labeling / mix-up (6 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Loxapine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Loxapine recalls on record

none so far in 2026; 10 on record, newest first
Class II · Moderate risk

Loxapine Capsules

GMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violations that would place Loxapine at risk for cross contamination

Terminated Cross-contamination Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-903-20 D-0823-2018
Class II · Moderate risk

Loxapine Capsules

GMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violations that would place Loxapine at risk for cross contamination

Terminated Cross-contamination Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-902-20 D-0822-2018
Class II · Moderate risk

Loxapine Capsules

CGMP Deviations

Terminated cGMP deviation Mylan Pharmaceuticals Inc. NDC 0378-7050-01 D-0825-2018
Class II · Moderate risk

Loxapine Capsules

CGMP Deviations

Terminated cGMP deviation Mylan Pharmaceuticals Inc. NDC 0378-7025-01 D-0824-2018
Class II · Moderate risk

Loxapine

Labeling: Label Mixup: LOXAPINE, Capsule, 5 mg may have potentially been mislabeled as the following drug: SERTRALINE HCL, Tablet, 50 mg, NDC 16714061204, Pedigree: AD46426_1, EXP: 5/15/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-961-2014
Class III · Low risk

Loxitane Capsules

Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

Terminated Labeling / mix-up Watson Laboratories Inc NDC 52544-495-01 D-1403-2012
Class III · Low risk

Loxapine Capsules USP

Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

Terminated Labeling / mix-up Watson Laboratories Inc NDC 0591-0372-01 D-1402-2012
Class III · Low risk

Loxapine Capsules USP

Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

Terminated Labeling / mix-up Watson Laboratories Inc NDC 0591-0371-01 D-1401-2012
Class III · Low risk

Loxapine Capsules USP

Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

Terminated Labeling / mix-up Watson Laboratories Inc NDC 0591-0370-01 D-1400-2012
Class III · Low risk

Loxapine Capsules USP

Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

Terminated Labeling / mix-up Watson Laboratories Inc NDC 00591-0369-01 D-1399-2012